---
figid: PMC7375019__fendo-11-00526-g0001
figlink: pmc/articles/PMC7375019/figure/F1/
number: F1
caption: Schematic representation of the activation of RAGE axis in Sars-Cov-2 infected
  cells in DM patients. Hyperglycemia enhances the production of RAGE ligands that
  prompt viral replication and increase RAGE signaling activation thus contributing
  to NRLP3 inflammasome priming and activation. Cytokine production and HMGB1 passive
  secretion contribute to dysregulated immune cell responses like M1 macrophages polarization,
  NETs formation, altered Th17 lymphocytes differentiation, thus paving the way for
  the cytokine storm. The preexisting endothelial dysfunction of DM patients and the
  ability of HMGB1 to activate platelets contribute to the pathogenesis of lung-centric
  and eventually multiorgan intravascular coagulopathy. Side panel shows druggable
  targets of molecular and clinical intervention. Targeting the RAGE pathway may represent
  a useful and feasible strategy for controlling severe ARDS and coagulopathy, particularly
  in DM patients. DPP4, Dipeptidyl-peptidase 4; SGLT2, Sodium-Glucose Cotransporter
  2; LMWH, Low Molecular Weights Heparins.
pmcid: PMC7375019
papertitle: 'COVID-19 and Diabetes: The Importance of Controlling RAGE.'
reftext: Ernestina M. De Francesco, et al. Front Endocrinol (Lausanne). 2020;11:526.
pmc_ranked_result_index: '84308'
pathway_score: 0.9504079
filename: fendo-11-00526-g0001.jpg
figtitle: Activation of RAGE axis in Sars-Cov-2 infected cells in DM patients
year: '2020'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7375019__fendo-11-00526-g0001.html
  '@type': Dataset
  description: Schematic representation of the activation of RAGE axis in Sars-Cov-2
    infected cells in DM patients. Hyperglycemia enhances the production of RAGE ligands
    that prompt viral replication and increase RAGE signaling activation thus contributing
    to NRLP3 inflammasome priming and activation. Cytokine production and HMGB1 passive
    secretion contribute to dysregulated immune cell responses like M1 macrophages
    polarization, NETs formation, altered Th17 lymphocytes differentiation, thus paving
    the way for the cytokine storm. The preexisting endothelial dysfunction of DM
    patients and the ability of HMGB1 to activate platelets contribute to the pathogenesis
    of lung-centric and eventually multiorgan intravascular coagulopathy. Side panel
    shows druggable targets of molecular and clinical intervention. Targeting the
    RAGE pathway may represent a useful and feasible strategy for controlling severe
    ARDS and coagulopathy, particularly in DM patients. DPP4, Dipeptidyl-peptidase
    4; SGLT2, Sodium-Glucose Cotransporter 2; LMWH, Low Molecular Weights Heparins.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HMGB1
  - AGER
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
  - NLRP3
  - DPP4
  - SLC5A2
  - ACE
  - IL1B
  - IL18
  - SPINK5
  - IL17A
  - IL1A
  - IL22
  - IL6
  - Pyridixamine
  - Aminoguanidine
  - Cloroquine
  - Metformin
  - Statins
  - OXIDATIVE
genes:
- word: HMGB1
  symbol: HMGB1
  source: hgnc_symbol
  hgnc_symbol: HMGB1
  entrez: '3146'
- word: RAGE
  symbol: RAGE
  source: hgnc_alias_symbol
  hgnc_symbol: AGER
  entrez: '177'
- word: RAGE
  symbol: RAGE
  source: hgnc_alias_symbol
  hgnc_symbol: AGER
  entrez: '177'
- word: RAGE
  symbol: RAGE
  source: hgnc_alias_symbol
  hgnc_symbol: AGER
  entrez: '177'
- word: RAGE
  symbol: RAGE
  source: hgnc_alias_symbol
  hgnc_symbol: AGER
  entrez: '177'
- word: RAGE
  symbol: RAGE
  source: hgnc_alias_symbol
  hgnc_symbol: AGER
  entrez: '177'
- word: NF-kB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-kB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NF-kB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF-kB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF-kB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: NLRP3
  symbol: NLRP3
  source: hgnc_symbol
  hgnc_symbol: NLRP3
  entrez: '114548'
- word: HMGB-1
  symbol: HMGB1
  source: hgnc_symbol
  hgnc_symbol: HMGB1
  entrez: '3146'
- word: HMGB-1
  symbol: HMGB1
  source: hgnc_symbol
  hgnc_symbol: HMGB1
  entrez: '3146'
- word: HMGB1
  symbol: HMGB1
  source: hgnc_symbol
  hgnc_symbol: HMGB1
  entrez: '3146'
- word: DPP4
  symbol: DPP4
  source: hgnc_symbol
  hgnc_symbol: DPP4
  entrez: '1803'
- word: SGLT2
  symbol: SGLT2
  source: hgnc_prev_symbol
  hgnc_symbol: SLC5A2
  entrez: '6524'
- word: ACE
  symbol: ACE
  source: hgnc_symbol
  hgnc_symbol: ACE
  entrez: '1636'
- word: IL-1b/IL-18
  symbol: IL-1B
  source: hgnc_alias_symbol
  hgnc_symbol: IL1B
  entrez: '3553'
- word: IL-1b/IL-18
  symbol: IL-18
  source: hgnc_alias_symbol
  hgnc_symbol: IL18
  entrez: '3606'
- word: proll-1b/proll-18IL-1b/IL-18
  symbol: IL-18
  source: hgnc_alias_symbol
  hgnc_symbol: IL18
  entrez: '3606'
- word: HMGB1
  symbol: HMGB1
  source: hgnc_symbol
  hgnc_symbol: HMGB1
  entrez: '3146'
- word: NETS
  symbol: NETS
  source: hgnc_alias_symbol
  hgnc_symbol: SPINK5
  entrez: '11005'
- word: HMGB1
  symbol: HMGB1
  source: hgnc_symbol
  hgnc_symbol: HMGB1
  entrez: '3146'
- word: IL-17
  symbol: IL-17
  source: hgnc_alias_symbol
  hgnc_symbol: IL17A
  entrez: '3605'
- word: HMGB1
  symbol: HMGB1
  source: hgnc_symbol
  hgnc_symbol: HMGB1
  entrez: '3146'
- word: IL-1
  symbol: IL1
  source: bioentities_symbol
  hgnc_symbol: IL1A
  entrez: '3552'
- word: IL-1
  symbol: IL1
  source: bioentities_symbol
  hgnc_symbol: IL1B
  entrez: '3553'
- word: IL-22
  symbol: IL22
  source: hgnc_symbol
  hgnc_symbol: IL22
  entrez: '50616'
- word: IL-6
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: IL-6
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
chemicals:
- word: Pyridixamine
  source: ''
  identifier: ''
- word: Aminoguanidine
  source: MESH
  identifier: C004479
- word: Cloroquine
  source: MESH
  identifier: C035033
- word: Metformin
  source: MESH
  identifier: D008687
- word: Statins
  source: MESH
  identifier: D019821
diseases:
- word: OXIDATIVE
  source: MESH
  identifier: D004194
figid_alias: PMC7375019__F1
redirect_from: /figures/PMC7375019__F1
figtype: Figure
---
